172 related articles for article (PubMed ID: 23285072)
1. Taenia taeniaeformis in rat favors protracted skin lesions caused by Sporothrix schenckii infection: Dectin-1 and IL-17 are dispensable for clearance of this fungus.
Zhang X; Zhang J; Huang H; Xue R; Hu X; Li M; Zhong Y; Yuan L
PLoS One; 2012; 7(12):e52514. PubMed ID: 23285072
[TBL] [Abstract][Full Text] [Related]
2. Dectin-1 expression by macrophages and related antifungal mechanisms in a murine model of Sporothrix schenckii sensu stricto systemic infection.
Jellmayer JA; Ferreira LS; Manente FA; Gonçalves AC; Polesi MC; Batista-Duharte A; Carlos IZ
Microb Pathog; 2017 Sep; 110():78-84. PubMed ID: 28645771
[TBL] [Abstract][Full Text] [Related]
3. Skin Mast Cells Contribute to
Jiao Q; Luo Y; Scheffel J; Geng P; Wang Y; Frischbutter S; Li R; Maurer M; Zhao Z
Front Immunol; 2020; 11():469. PubMed ID: 32265923
[No Abstract] [Full Text] [Related]
4. Involvement of major components from Sporothrix schenckii cell wall in the caspase-1 activation, nitric oxide and cytokines production during experimental sporotrichosis.
Gonçalves AC; Maia DC; Ferreira LS; Monnazzi LG; Alegranci P; Placeres MC; Batista-Duharte A; Carlos IZ
Mycopathologia; 2015 Feb; 179(1-2):21-30. PubMed ID: 25205196
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells are pivotal for in vivo protection following systemic infection by Sporothrix schenckii.
Ferreira LS; Portuondo DL; Polesi MC; Carlos IZ
Immunology; 2018 Dec; 155(4):467-476. PubMed ID: 30030839
[TBL] [Abstract][Full Text] [Related]
6. Is There Any Difference between the In Situ and Systemic IL-10 and IFN-γ Production when Clinical Forms of Cutaneous Sporotrichosis Are Compared?
Morgado FN; Schubach AO; Pimentel MI; Lyra MR; Vasconcellos ÉC; Valete-Rosalino CM; Conceição-Silva F
PLoS One; 2016; 11(9):e0162764. PubMed ID: 27622513
[TBL] [Abstract][Full Text] [Related]
7. Response of Cytokines and Hydrogen Peroxide to Sporothrix schenckii Exoantigen in Systemic Experimental Infection.
Maia DC; Gonçalves AC; Ferreira LS; Manente FA; Portuondo DL; Vellosa JC; Polesi MC; Batista-Duharte A; Carlos IZ
Mycopathologia; 2016 Apr; 181(3-4):207-15. PubMed ID: 26603044
[TBL] [Abstract][Full Text] [Related]
8. Mast cell activation by conidia of Sporothrix schenckii: role in the severity of infection.
Romo-Lozano Y; Hernández-Hernández F; Salinas E
Scand J Immunol; 2012 Jul; 76(1):11-20. PubMed ID: 22486186
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory activity of Vismia guianensis (Aubl.) Pers. extracts and antifungal activity against Sporothrix schenckii.
Oliveira AH; de Oliveira GG; Carnevale Neto F; Portuondo DF; Batista-Duharte A; Carlos IZ
J Ethnopharmacol; 2017 Jan; 195():266-274. PubMed ID: 27856302
[TBL] [Abstract][Full Text] [Related]
10. Differential recognition and cytokine induction by the peptidorhamnomannan from Sporothrix brasiliensis and S. Schenckii.
Kischkel B; Lopes-Bezerra L; Taborda CP; Joosten LAB; Dos Santos JC; Netea MG
Cell Immunol; 2022 Aug; 378():104555. PubMed ID: 35696852
[TBL] [Abstract][Full Text] [Related]
11. Sporothrix brasiliensis induces a more severe disease associated with sustained Th17 and regulatory T cells responses than Sporothrix schenckii sensu stricto in mice.
Batista-Duharte A; Téllez-Martínez D; Roberto de Andrade C; Portuondo DL; Jellmayer JA; Polesi MC; Carlos IZ
Fungal Biol; 2018 Dec; 122(12):1163-1170. PubMed ID: 30449354
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell are able to differentially recognize Sporothrix schenckii antigens and promote Th1/Th17 response in vitro.
Verdan FF; Faleiros JC; Ferreira LS; Monnazzi LG; Maia DC; Tansine A; Placeres MC; Carlos IZ; Santos-Junior RR
Immunobiology; 2012 Aug; 217(8):788-94. PubMed ID: 22656886
[TBL] [Abstract][Full Text] [Related]
13. The NLRP3 inflammasome contributes to host protection during Sporothrix schenckii infection.
Gonçalves AC; Ferreira LS; Manente FA; de Faria CMQG; Polesi MC; de Andrade CR; Zamboni DS; Carlos IZ
Immunology; 2017 Jun; 151(2):154-166. PubMed ID: 28140444
[TBL] [Abstract][Full Text] [Related]
14. A cell wall protein-based vaccine candidate induce protective immune response against Sporothrix schenckii infection.
Portuondo DL; Batista-Duharte A; Ferreira LS; Martínez DT; Polesi MC; Duarte RA; de Paula E Silva AC; Marcos CM; Almeida AM; Carlos IZ
Immunobiology; 2016 Feb; 221(2):300-9. PubMed ID: 26547105
[TBL] [Abstract][Full Text] [Related]
15. Recombinant murine IL-12 promotes a protective Th1/cellular response in Mongolian gerbils infected with Sporothrix schenckii.
Flores-García A; Velarde-Félix JS; Garibaldi-Becerra V; Rangel-Villalobos H; Torres-Bugarín O; Zepeda-Carrillo EA; Ruíz-Bernés S; Ochoa-Ramírez LA
J Chemother; 2015 Feb; 27(2):87-93. PubMed ID: 24548095
[TBL] [Abstract][Full Text] [Related]
16. Optimal clearance of Sporothrix schenckii requires an intact Th17 response in a mouse model of systemic infection.
Ferreira LS; Gonçalves AC; Portuondo DL; Maia DC; Placeres MC; Batista-Duharte A; Carlos IZ
Immunobiology; 2015 Aug; 220(8):985-92. PubMed ID: 25776919
[TBL] [Abstract][Full Text] [Related]
17. Sporothrix schenckii yeasts induce ERK pathway activation and secretion of IL-6 and TNF-α in rat mast cells, but no degranulation.
Romo-Lozano Y; Hernández-Hernández F; Salinas E
Med Mycol; 2014 Nov; 52(8):862-8. PubMed ID: 25262023
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress in rats experimentally infected by Sporothrix schenckii.
Castro VSP; Da Silva AS; Thomé GR; Wolkmer P; Castro JLC; Costa MM; Graça DL; Oliveira DC; Alves SH; Schetinger MRC; Lopes STA; Stefani LM; Azevedo MI; Baldissera MD; Andrade CM
Microb Pathog; 2017 Jun; 107():1-5. PubMed ID: 28286151
[TBL] [Abstract][Full Text] [Related]
19. Antibodies Against Sporothrix schenckii Enhance TNF-α Production and Killing by Macrophages.
Franco Dde L; Nascimento RC; Ferreira KS; Almeida SR
Scand J Immunol; 2012 Feb; 75(2):142-6. PubMed ID: 21923739
[TBL] [Abstract][Full Text] [Related]
20. Differential induction of Th1-prone immunity by human dendritic cells activated with Sporothrix schenckii of cutaneous and visceral origins to determine their different virulence.
Uenotsuchi T; Takeuchi S; Matsuda T; Urabe K; Koga T; Uchi H; Nakahara T; Fukagawa S; Kawasaki M; Kajiwara H; Yoshida S; Moroi Y; Furue M
Int Immunol; 2006 Dec; 18(12):1637-46. PubMed ID: 17035348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
